Stoke Therapeutics STOK - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) Options

Stoke Therapeutics Inc (STOK)

10.68

0.05

(0.47%)

Closed 17 February 8:00AM

Delayed by 15 minutes

10.65

-0.03

(-0.28%)

After Hours: 10:56AM

Delayed by 15 minutes

STOK Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	6.40	10.50	10.20	8.45	-0.00	0.00 %	0	1	-
5.00	5.30	7.10	7.80	6.20	0.00	0.00 %	0	1,806	-
7.50	2.35	4.30	2.50	3.325	0.00	0.00 %	0	532	-
10.00	0.55	4.90	0.65	2.725	0.00	0.00 %	0	786	-
12.50	0.10	0.60	2.08	0.35	0.00	0.00 %	0	533	-
15.00	0.05	0.75	0.10	0.40	0.00	0.00 %	0	19	-
17.50	0.05	4.90	0.05	2.475	0.00	0.00 %	0	4	-
20.00	0.35	4.90	0.35	2.625	0.00	0.00 %	0	1	-
22.50	0.21	4.90	0.21	2.555	0.00	0.00 %	0	3	-
25.00	0.35	4.90	0.35	2.625	0.00	0.00 %	0	1	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.05	0.05	0.05	0.05	0.00	0.00 %	0	110	-
7.50	0.05	0.05	0.05	0.05	0.00	0.00 %	39	173	15/2/2025
10.00	0.15	2.55	0.50	1.35	0.00	0.00 %	0	158	-
12.50	0.20	4.90	2.50	2.55	0.00	0.00 %	0	66	-
15.00	2.00	6.50	3.75	4.25	0.00	0.00 %	0	0	-
17.50	4.50	9.00	0.00	6.75	0.00	0.00 %	0	0	-
20.00	7.00	11.50	0.00	9.25	0.00	0.00 %	0	0	-
22.50	9.60	14.00	0.00	11.80	0.00	0.00 %	0	0	-
25.00	12.00	16.50	0.00	14.25	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	489.28M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	417.31M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
INTCIntel Corporation	US$ 23.60 (-2.20%)	230.26M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	194.99M

PonkenPlonken

PonkenPlonken 3 months ago

I am so STOKED about this company. They were doing this before they all figured out you need RNA science for gene therapy.
See SRPT ARWR deal! another AAV based gene tx seeking RNAI

Monksdream

Monksdream 5 months ago

Zardiw

Zardiw 11 months ago

$STOK Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:

Z

TimeFades

TimeFades 11 months ago

Choppy day shoulda just stuck with my morning short

TimeFades

TimeFades 11 months ago

Got bullish again and covered

TimeFades

TimeFades 11 months ago

Invest-in-America

Invest-in-America 11 months ago

STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)

Stoke Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions